Avtor/Urednik		Dolenc, Jure; Koželj, Mirta; Zver, Samo
Naslov		Obravnava hematoloških bolnikov, zdravljenih s kardiotoksičnimi zdravili
Prevedeni naslov		Management of haematological pateints treated with cardiotoxic drugs
Tip		članek
Vir		Zdrav Vestn
Vol. in št.		Letnik 77, št. Suppl 1
Leto izdaje		2008
Obseg		str. I-19-24
Jezik		slo
Abstrakt		Background Recent advances in the treatment of malign haematological deseases with chemotherapy have led to significant improvement in prognosis and quality of life of the pacients. The same drugs can lead to development of serious cardiac side effects, especially the syndrome of heart failure. Anthracycline drugs are best known for their cardiotoxicity, the role of other drugs is less well understood. Conclusions Predisposing factors to cardiotoxicity should be taken into consideration when dealing with such pacients. Careful history, clinical examination, electrocardiography, echocardiography and NT-proBNP measurement should be performed prior and at the end of the treatment with cardiotoxic drugs. Pacients with slightest clinical, laboratory or echocardiographic parameters of developing heart failure should immediately be reffered to a cardiologist to start with appropriate treatment.